Risk factor
Low price volatility
Profitability factor
Strong growth
About
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates in two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, patch injectors, and wearable injectors, as well...
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'expensive' o
Target Price
The average target price of YPSN.SW is 411 and suggests 23% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell